Treatment of myoclonic seizures

Pasquale Striano, Vincenzo Belcastro

Research output: Contribution to journalArticle

Abstract

Myoclonic seizures are sudden, brief, shock-like contractions that can vary in distribution and intensity. They may be present in different epilepsy syndromes, including some idiopathic generalized epilepsy, epileptic encephalopathies and progressive myoclonus epilepsies. Despite the fact that there are many studies about the pathophysiology of myoclonic seizures and clear descriptions of the different myoclonic epilepsy syndromes, relatively little has been written on treatment. Valproate and some benzodiazepines are widely used to treat myoclonic seizures. In addition, more treatment options exist today as there is emerging evidence to support the efficacy of some newer antiepileptic drugs. On the other hand, some myoclonic epilepsies remain refractory to drug treatment and some antiepileptic drugs may exacerbate or even induce myoclonus. In the coming years, better understanding of mechanisms of myoclonic seizures and myoclonic epilepsies could result in great improvement of therapy and the quality of life of patients.

Original languageEnglish
Pages (from-to)1411-1418
Number of pages8
JournalExpert Review of Neurotherapeutics
Volume12
Issue number12
DOIs
Publication statusPublished - Dec 2012

Fingerprint

Myoclonic Epilepsy
Seizures
Anticonvulsants
Progressive Myoclonic Epilepsy
Myoclonus
Valproic Acid
Brain Diseases
Therapeutics
Benzodiazepines
Shock
Epilepsy
Quality of Life
Pharmaceutical Preparations

Keywords

  • antiepileptic drugs
  • clinical trials
  • epilepsy
  • myoclonic seizures
  • myoclonus
  • review
  • treatment

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Pharmacology (medical)

Cite this

Treatment of myoclonic seizures. / Striano, Pasquale; Belcastro, Vincenzo.

In: Expert Review of Neurotherapeutics, Vol. 12, No. 12, 12.2012, p. 1411-1418.

Research output: Contribution to journalArticle

Striano, Pasquale ; Belcastro, Vincenzo. / Treatment of myoclonic seizures. In: Expert Review of Neurotherapeutics. 2012 ; Vol. 12, No. 12. pp. 1411-1418.
@article{11ddc8a2d79f4222afc27edb62bc8599,
title = "Treatment of myoclonic seizures",
abstract = "Myoclonic seizures are sudden, brief, shock-like contractions that can vary in distribution and intensity. They may be present in different epilepsy syndromes, including some idiopathic generalized epilepsy, epileptic encephalopathies and progressive myoclonus epilepsies. Despite the fact that there are many studies about the pathophysiology of myoclonic seizures and clear descriptions of the different myoclonic epilepsy syndromes, relatively little has been written on treatment. Valproate and some benzodiazepines are widely used to treat myoclonic seizures. In addition, more treatment options exist today as there is emerging evidence to support the efficacy of some newer antiepileptic drugs. On the other hand, some myoclonic epilepsies remain refractory to drug treatment and some antiepileptic drugs may exacerbate or even induce myoclonus. In the coming years, better understanding of mechanisms of myoclonic seizures and myoclonic epilepsies could result in great improvement of therapy and the quality of life of patients.",
keywords = "antiepileptic drugs, clinical trials, epilepsy, myoclonic seizures, myoclonus, review, treatment",
author = "Pasquale Striano and Vincenzo Belcastro",
year = "2012",
month = "12",
doi = "10.1586/ern.12.90",
language = "English",
volume = "12",
pages = "1411--1418",
journal = "Expert Review of Neurotherapeutics",
issn = "1473-7175",
publisher = "Expert Reviews Ltd.",
number = "12",

}

TY - JOUR

T1 - Treatment of myoclonic seizures

AU - Striano, Pasquale

AU - Belcastro, Vincenzo

PY - 2012/12

Y1 - 2012/12

N2 - Myoclonic seizures are sudden, brief, shock-like contractions that can vary in distribution and intensity. They may be present in different epilepsy syndromes, including some idiopathic generalized epilepsy, epileptic encephalopathies and progressive myoclonus epilepsies. Despite the fact that there are many studies about the pathophysiology of myoclonic seizures and clear descriptions of the different myoclonic epilepsy syndromes, relatively little has been written on treatment. Valproate and some benzodiazepines are widely used to treat myoclonic seizures. In addition, more treatment options exist today as there is emerging evidence to support the efficacy of some newer antiepileptic drugs. On the other hand, some myoclonic epilepsies remain refractory to drug treatment and some antiepileptic drugs may exacerbate or even induce myoclonus. In the coming years, better understanding of mechanisms of myoclonic seizures and myoclonic epilepsies could result in great improvement of therapy and the quality of life of patients.

AB - Myoclonic seizures are sudden, brief, shock-like contractions that can vary in distribution and intensity. They may be present in different epilepsy syndromes, including some idiopathic generalized epilepsy, epileptic encephalopathies and progressive myoclonus epilepsies. Despite the fact that there are many studies about the pathophysiology of myoclonic seizures and clear descriptions of the different myoclonic epilepsy syndromes, relatively little has been written on treatment. Valproate and some benzodiazepines are widely used to treat myoclonic seizures. In addition, more treatment options exist today as there is emerging evidence to support the efficacy of some newer antiepileptic drugs. On the other hand, some myoclonic epilepsies remain refractory to drug treatment and some antiepileptic drugs may exacerbate or even induce myoclonus. In the coming years, better understanding of mechanisms of myoclonic seizures and myoclonic epilepsies could result in great improvement of therapy and the quality of life of patients.

KW - antiepileptic drugs

KW - clinical trials

KW - epilepsy

KW - myoclonic seizures

KW - myoclonus

KW - review

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=84871092007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871092007&partnerID=8YFLogxK

U2 - 10.1586/ern.12.90

DO - 10.1586/ern.12.90

M3 - Article

C2 - 23237348

AN - SCOPUS:84871092007

VL - 12

SP - 1411

EP - 1418

JO - Expert Review of Neurotherapeutics

JF - Expert Review of Neurotherapeutics

SN - 1473-7175

IS - 12

ER -